Keratitis Sicca (Sjögren’s Eye Disease)
Overview
Keratitis sicca, commonly called Sjögren’s eye disease, is a chronic inflammation of the cornea that results from severe dryness of the ocular surface. The condition is a manifestation of systemic Sjögren’s syndrome—a autoimmune disorder in which the body’s immune system mistakenly attacks the moisture‑producing glands, especially the lacrimal (tear) and salivary glands.
Who it affects: The disease predominantly affects women (approximately 9 : 1 female‑to‑male ratio) and most often appears between the ages of 40 and 60, although it can occur at any age, even in children with congenital forms of dry eye.[1][2]
Prevalence: Primary Sjögren’s syndrome occurs in about 0.1–0.6 % of the general population, while secondary Sjögren’s (associated with other autoimmune diseases such as rheumatoid arthritis or lupus) adds another 0.5 % prevalence.[3] Of those with Sjögren’s, up to 70 % develop ocular involvement, and 30–40 % progress to keratitis sicca that threatens vision.[4]
Symptoms
Keratitis sicca produces a spectrum of ocular complaints. The severity can fluctuate throughout the day and is often worse in dry, windy, or air‑conditioned environments.
- Dryness or grittiness – a persistent feeling that the eye is “sand‑filled.”
- Burning or stinging sensation – may feel like a mild electric shock.
- Foreign‑body sensation – the feeling that something is lodged in the eye.
- Redness (conjunctival injection) – due to irritation of the surface.
- Excessive tearing (reflex tearing) – paradoxical watering that attempts to compensate for dryness.
- Blurred vision – often improves with blinking.
- Photophobia – sensitivity to bright light.
- Difficulty wearing contact lenses – intolerance is common.
- Reduced tear meniscus height – a clinical sign seen on slit‑lamp exam.
- Corneal erosions or ulcerations – surface breaks that can cause pain and visual loss.
- Eye fatigue – especially after reading or screen use.
Systemic Sjögren’s symptoms—dry mouth, joint pain, fatigue, and swelling of salivary glands—often accompany the eye disease and can help guide diagnosis.[5]
Causes and Risk Factors
Underlying cause
Keratitis sicca is not a primary infection; it results from an autoimmune attack on the lacrimal glands that reduces tear production and alters tear composition. The resulting hyper‑osmolar tear film triggers an inflammatory cascade on the corneal epithelium, leading to cellular damage and keratitis.
Risk factors
- Female sex – hormonal influences (estrogen) may modulate immune tolerance.
- Age >40 years – immune dysregulation increases with age.
- Existing autoimmune disease – rheumatoid arthritis, systemic lupus erythematosus, scleroderma, or thyroiditis.
- Family history of Sjögren’s or other autoimmune disorders.
- Medications that reduce tear production – antihistamines, antidepressants, isotretinoin, β‑blockers.
- Environmental exposures – low humidity, wind, air‑conditioning, smoke.
- Viral infections – Epstein‑Barr virus and hepatitis C have been linked to secondary Sjögren’s.
Diagnosis
Because dry eye symptoms are common, a systematic approach is essential to differentiate keratitis sicca from other ocular surface disorders.
Clinical evaluation
- Medical history – detailed review of systemic symptoms, medication list, and family history.
- Ophthalmic examination – slit‑lamp biomicroscopy to assess corneal staining, tear film break‑up time (TBUT), and meibomian gland function.
Important diagnostic tests
- Tear production tests
- Schirmer I test – filter paper placed under the lower eyelid for 5 minutes; ≤5 mm wetting suggests severe aqueous deficiency.
- Schirmer with anesthesia – isolates basal tear secretion.
- Tear film stability
- Break‑up time (TBUT) – fluorescein dye; a TBUT <10 seconds indicates instability.
- Ocular surface staining
- Fluorescein, lissamine green, or rose bengal staining highlights damaged epithelial cells. Grading systems (e.g., Oxford or NEI) quantify severity.
- Imaging
- Anterior segment optical coherence tomography (AS‑OCT) – measures epithelial thickness and tear meniscus.
- Serologic tests for Sjögren’s
- Anti‑SSA/Ro and anti‑SSB/La antibodies (positive in ~60–70 % of cases).
- ANA, rheumatoid factor, and elevated ESR/CRP may be supportive.
- Minor salivary gland biopsy – occasionally performed when systemic diagnosis is uncertain.
Diagnosis follows the 2016 ACR/EULAR classification criteria for Sjögren’s syndrome, which allocate points for ocular signs, serology, and systemic features.[6]
Treatment Options
Management aims to restore tear film stability, control inflammation, and protect the cornea. Treatment is individualized based on severity.
1. Artificial tears and lubricants
- Preservative‑free drops (e.g., sodium hyaluronate 0.1–0.4 %). Use 4–6 times daily.
- Gel or ointment formulations for nighttime protection.
2. Tear conservation strategies
- Punctal plugs – silicone or collagen plugs placed in the lacrimal puncta to reduce drainage.
- Eyelid tapping or “blink training” – improves tear distribution.
3. Anti‑inflammatory therapy
- Topical corticosteroids (e.g., loteprednol 0.5 % BID) for acute inflammation; limited to short courses to avoid cataract or glaucoma.
- Cycloplegic agents (e.g., cyclosporine A 0.05 % ophthalmic emulsion) – improve tear production by reducing ocular surface inflammation; benefits often appear after 4–6 weeks.
- Lifitegrast 5 % ophthalmic solution – an FDA‑approved lymphocyte function‑associated antigen‑1 (LFA‑1) antagonist that reduces inflammation.
4. Systemic immunomodulators (for moderate‑to‑severe disease)
- Hydroxychloroquine 200–400 mg daily – commonly used for systemic Sjögren’s; may improve dry eye signs.
- Systemic corticosteroids – short bursts for acute exacerbations.
- Biologics – rituximab (anti‑CD20) has shown benefit in refractory keratitis sicca in several trials, though insurance approval can be challenging.[7]
5. Procedural interventions
- Meibomian gland expression – manual or thermal (LipiFlow) to improve lipid layer.
- Autologous serum eye drops – 20–50 % serum containing growth factors; reserved for severe epithelial defects.
- Amniotic membrane transplantation – for persistent corneal ulceration.
- Corneal bandage contact lenses – protect the surface while healing.
6. Lifestyle and environmental modifications
- Humidifier use (30–40 % relative humidity) at home and work.
- Avoid direct airflow (fans, air‑conditioners) directed at the face.
- Take regular “20‑20‑20” breaks during screen use (every 20 minutes look at something 20 feet away for 20 seconds).
- Stay well‑hydrated (≥2 L water/day) and maintain a balanced omega‑3 rich diet.
Living with Keratitis sicca (Sjögren’s eye disease)
Daily management tips
- Stick to a lubricating schedule – keep artificial tears on hand and apply before and after activities that strain the eyes (reading, driving, screen time).
- Protect against wind and dust – wear wrap‑around sunglasses or protective goggles outdoors.
- Warm compresses – 5‑10 minutes, 2–3 times daily, to improve meibomian gland secretion.
- Eyelid hygiene – gentle lid scrubs with diluted baby shampoo or commercial lid wipes.
- Monitor medication side effects – inform your ophthalmologist if you start new systemic drugs that could worsen dryness.
- Regular follow‑up – at least every 6 months, or sooner if symptoms change.
- Record symptom patterns – a simple diary helps clinicians adjust therapy.
Psychosocial aspects
Chronic eye discomfort can affect quality of life, leading to fatigue, reduced productivity, and mood disturbances. Consider counseling, support groups, or patient advocacy organizations (e.g., Sjögren’s Syndrome Foundation) to share experiences and coping strategies.[8]
Prevention
Because keratitis sicca is a manifestation of an underlying autoimmune condition, complete “prevention” is not possible. However, risk reduction strategies can delay onset or lessen severity:
- Early diagnosis and treatment of systemic Sjögren’s syndrome.
- Avoid smoking and exposure to second‑hand smoke.
- Limit prolonged use of preservative‑containing eye drops; choose preservative‑free options.
- Maintain optimal hydration and a diet rich in omega‑3 fatty acids (flaxseed, fish).
- Regular eye examinations, especially if you have another autoimmune disease.
Complications
If left untreated or inadequately controlled, keratitis sicca can lead to serious ocular problems:
- Corneal ulceration – can progress to perforation, requiring surgical repair.
- Scarring (fibrosis) – may cause permanent visual impairment.
- Infectious keratitis – dry, compromised epithelium is a portal for bacteria, fungi, or viruses.
- Secondary glaucoma – from chronic steroid use.
- Reduced quality of life – persistent pain, reading difficulty, and social limitation.
When to Seek Emergency Care
- Sudden, severe eye pain that does not improve with lubricants.
- Rapid loss of vision or a large “black spot” in the visual field.
- Persistent photophobia combined with a watery discharge.
- Signs of a corneal ulcer or perforation – a white or gray spot on the cornea, hazy vision, or a feeling that something is “stuck” under the eyelid.
- Swelling of the eyelids with redness that spreads beyond the eye (possible orbital cellulitis).
These situations require immediate evaluation to prevent permanent damage.
References
- Mayo Clinic. “Sjogren’s syndrome.” Updated 2023. https://www.mayoclinic.org
- National Institute of Arthritis and Musculoskeletal and Skin Diseases. “Sjogren’s Syndrome.” 2022. https://www.niams.nih.gov
- Cleveland Clinic. “Prevalence of Sjogren’s Syndrome.” 2021. https://my.clevelandclinic.org
- American Academy of Ophthalmology. “Dry Eye Disease (Keratitis Sicca).” 2023. https://www.aao.org
- CDC. “Autoimmune Diseases.” 2022. https://www.cdc.gov
- Shiboski CH, et al. “2016 ACR/EULAR Classification Criteria for Sjogren’s Syndrome.” *Arthritis Rheumatol.* 2017;69(1):35‑45.
- Richey K, et al. “Rituximab for refractory keratitis sicca in Sjögren’s syndrome: a systematic review.” *Ophthalmology*. 2020;127(10):1402‑1411.
- Sjögren’s Syndrome Foundation. “Living with Sjögren’s – Resources.” 2024. https://www.sjogrens.org